Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopause

  • Technology appraisal guidance
  • TA1143
  • Published: 

Information for the public

Fezolinetant (Veoza) is available on the NHS. It is a possible treatment for moderate to severe vasomotor symptoms associated with menopause when hormone replacement therapy (HRT) is unsuitable.

Vasomotor symptoms are a hot sensation with sweating (commonly known as hot flushes). You may also experience a rapid heartbeat, chills and anxiety. With moderate symptoms, you can carry on doing usual activities. Severe vasomotor symptoms stop you doing usual activities.

If you are not eligible for fezolinetant but are already having it, you should be able to continue until you and your healthcare professional decide when best to stop.

Is this treatment right for me?

Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. See our webpage on shared decision making.

Questions to think about

  • How well does it work compared with other treatments?
  • What are the risks or side effects? How likely are they?
  • How will the treatment affect my day-to-day life?
  • What happens if the treatment does not work?
  • What happens if I do not want to have treatment? Are there other treatments available?

Information and support

The NHS webpage on menopause may be a good place to find out more.

These organisations can give you advice and support:

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-9411-3

This page was last updated: